TOXICITY PROFILE OF DEXRAZOXANE (ZINECARDR, ICRF-187, ADR-529, NSC-169780), A MODULATOR OF DOXORUBICIN CARDIOTOXICITY

被引：25

作者：

CURRAN, CF ^{[1
]}

NARANG, PK ^{[1
]}

REYNOLDS, RD ^{[1
]}

机构：

[1] ADRIA LABS INC,MED SERV,COLUMBUS,OH 43216

来源：

CANCER TREATMENT REVIEWS | 1991年 / 18卷 / 04期

关键词：

D O I：

10.1016/0305-7372(91)90015-R

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：241 / 252

页数：12

共 90 条

[1]

AHMANN DL, 1978, CANCER TREAT REP, V62, P151

[2]

ARORA M, 1986, P AM ASSOC CANC RES, V27, P184

[3] RAZOXANE (ICRF-159) IN THE TREATMENT OF PSORIASIS [J].

ATHERTON, DJ ;

WELLS, RS ;

LAURENT, MR ;

WILLIAMS, YF .

BRITISH JOURNAL OF DERMATOLOGY, 1980, 102 (03) :307-317

[4] THERAPY-RELATED ACUTE NONLYMPHOCYTIC LEUKEMIA WITH INVERSION OF CHROMOSOME-16 AND A SUSTAINED REMISSION [J].

BAGLIN, TP ;

GALVIN, GP ;

POLLOCK, A .

CANCER GENETICS AND CYTOGENETICS, 1987, 27 (01) :167-169

[5]

BAKOWSKI MT, 1979, CANCER TREAT REP, V63, P127

[6] STUDY OF ANTITUMOR (PHASE-2) AND IMMUNOSUPPRESSIVE EFFECTS OF ICRF-159 IN PATIENTS WITH METASTATIC MELANOMA [J].

BELLET, RE ;

CATALANO, RB ;

DANNA, VG ;

BERD, DA ;

BERKELHAMMER, J ;

MASTRANGELO, MJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (8-9) :433-438

[7] ICRF-159 PLUS RADIATION VERSUS RADIATION-THERAPY ALONE IN CERVICAL-CARCINOMA - A DOUBLE-BLIND-STUDY [J].

BELLONI, C ;

MANGIONI, C ;

BORTOLOZZI, G ;

CARINELLI, S ;

DINCALCI, M ;

MAGGIONI, A ;

MORASCA, L .

ONCOLOGY, 1983, 40 (03) :181-185

[8]

BELT RJ, 1984, P AN M AM SOC CLIN, V3, P27

[9]

BHAVNANI M, 1987, LANCET, V2, P1085

[10]

Blum R H, 1990, Cancer Invest, V8, P267, DOI 10.3109/07357909009017580

← 1 2 3 4 5 6 7 8 9 →